Esperion Therapeutics Inc (ESPR)
2.065
+0.02
(+1.23%)
USD |
NASDAQ |
May 02, 16:00
2.09
+0.02
(+1.21%)
After-Hours: 20:00
Esperion Therapeutics Gross Profit (Quarterly): 20.80M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 20.80M |
September 30, 2023 | 20.59M |
June 30, 2023 | 19.00M |
March 31, 2023 | 12.68M |
December 31, 2022 | 14.66M |
September 30, 2022 | 12.47M |
June 30, 2022 | 9.665M |
March 31, 2022 | 11.71M |
December 31, 2021 | 10.33M |
September 30, 2021 | 8.851M |
Date | Value |
---|---|
June 30, 2021 | 38.86M |
March 31, 2021 | 6.194M |
December 31, 2020 | 7.95M |
September 30, 2020 | 3.558M |
June 30, 2020 | 211.84M |
March 31, 2020 | 1.809M |
December 31, 2019 | 0.982M |
September 30, 2019 | 0.981M |
June 30, 2019 | 0.982M |
March 31, 2019 | 145.42M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
0.981M
Minimum
Sep 2019
211.84M
Maximum
Jun 2020
21.78M
Average
10.33M
Median
Dec 2021
Gross Profit (Quarterly) Benchmarks
United Therapeutics Corp | 543.70M |
Dynavax Technologies Corp | 46.91M |
Heron Therapeutics Inc | 24.35M |
Aldeyra Therapeutics Inc | -- |
Deciphera Pharmaceuticals Inc | 46.51M |